Mitigation of therapeutic anti‐CD38 antibody interference with fab fragments: How well does it perform?
Sign Up to like & getrecommendations! Published in 2023 at "Transfusion"
DOI: 10.1111/trf.17253
Abstract: Administration of anti‐CD38 antibodies is a state‐of‐the‐art therapy for patients diagnosed with multiple myeloma (MM). However, this treatment frequently leads to pan‐agglutination of red blood cells (RBCs) in patients' serological testing making accurate blood typing… read more here.
Keywords: anti cd38; cd38 antibody; interference fab; antibody interference ... See more keywords